270 Life Sciences Private Capital
Startup rounds since 2018 with a 270 Life Sciences Private Capital investor on the board, and the firm's own fund filings.
Raises
14
since 2018
Unannounced
0
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name
Rounds
- Averna Therapeutics Inc.$85M
- Raintank Inc.$250M
- Enlaza Therapeutics, Inc.$15M
- Raintank Inc.$328M
- Enlaza Therapeutics, Inc.$84M
- Hasura, Inc.$103M
- Vanqua Bio, Inc.$85M
- Raintank Inc.$220M
- Raintank Inc.$35M
- Raintank Inc.$50M
- Raintank Inc.$29.6M
- Panther Labs Inc.$15M
- SpringWorks Therapeutics, Inc.$125M
- UCAN Co$5.75M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 2 | 0 |
| 2025 | 1 | 0 |
| 2024 | 2 | — |
| 2022 | 1 | — |
| 2021 | 5 | — |
| 2020 | 1 | — |
| 2019 | 1 | — |
| 2018 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| 270 Life Sciences Private Capital Fund II (US) LP | 16 Sep 2026 | Open-ended | — |
| 270 Life Sciences Private Capital Fund II (Cayman) LP | 16 Sep 2026 | Open-ended | — |
Listed because a 270 Life Sciences Private Capital fund's filing names a director of each company. A name match is not a verified identity.